Netherlands Halts Use of AstraZeneca COVID-19 Vaccine

By Channel News Asia
Global Research, March 15, 2021
Channel News Asia
Region:
Theme:

All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

***

The Netherlands will suspend the use of AstraZeneca’s COVID-19 vaccine until at least March 29 as a precaution, the Dutch government said on Sunday (Mar 14).

The move, which follows a similar decision by Ireland earlier in the day, is based on reports from Denmark and Norway of possible serious side effects, the government said.

Three health workers in Norway who had recently received the vaccine were being treated in hospital for bleeding, blood clots and a low count of blood platelets, its health authorities said on Saturday.

No such cases had been found yet in the Netherlands, the Dutch Health ministry said in a statement, adding that there was no proof yet of a direct link between the vaccine and the reports from Denmark and Norway.

The government said it would now wait for an investigation by the European Medicines Agency (EMA).

“We can’t allow any doubts about the vaccine,” Dutch Health minister Hugo de Jonge said.

“We have to make sure everything is right, so it is wise to pause for now.”

The Dutch late last week said there was no reason to stop using the vaccine, following reports of the formation of blood clots in some people who had been injected with it.

The EMA and the World Health Organisation have said there is no indication that these events were caused by the vaccination, and AstraZeneca has also said it had found no evidence of increased risk of deep-vein thrombosis.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Zero Hedge
Articles by: Channel News Asia

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]